Bone Cement for Spine Market By Type (Low Viscosity, Medium Viscosity, High Viscosity) , By Application (Vertebroplasty, Kyphoplasty) By End User (Hospitals, Specialty Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Bone Cement for Spine Market
The bone cement for spine market was valued at $101.2 million in 2023 and is projected to reach $168.6 million by 2033, growing at a CAGR of 5.3% from 2024 to 2033.
The chemical used as a bone cement for spine is polymethyl methacrylate. The cement is specifically used for spinal surgeries such as kyphoplasty and vertebroplasty. This cement is administered to provide support to weakened broken bones, provide them with strength, and aid in relieving pain. A major attribute of the bone cement is its ability to solidify quickly, providing instant structural support and stability to the spine.
Increase in the prevalence of spinal surgeries across the globe is a key driver of the bone cement for spine market. In addition, the exponentially growing elderly population with high bone fragility is boosting the demand for bone cement for spine. In recent times, the trend of using bone cement as a material for the designing of scaffolds and bone implants through additive manufacturing is acquiring noteworthy traction. This enables the creation of tailored spine implants, according to the specific requirement of patients. Furthermore, the use of bone cement as a carrier for localized drug delivery is gaining significant traction in the healthcare industry.
However, bone cement for spine remains highly susceptible to fragmentation & foreign substance reaction inside the body, which leads to threatening conditions such as prosthetic loosening and periprosthetic osteolysis. These reactions hamper the development of the market. On the contrary, a constant surge in the number of spinal surgeries is projected to present lucrative opportunities for the market development. According to the statistics of the World Health Organization, approximately 15.4 million individuals were suffering from spinal cord injuries in 2021 globally owing to several reasons such as road accidents, falls, or violence. Moreover, Statista—a global data and business intelligence platform—states that around 305,000 individuals in the U.S. had a spinal cord injury by the end of 2023. These eminent figures indicate a promising future for the bone cement for spine market.
Segment Review
The bone cement for spine market is segmented into type, application, end user, and region. On the basis of type, the market is divided into low viscosity, medium viscosity, and high viscosity. As per application, it is bifurcated into vertebroplasty and kyphoplasty. Depending on end user, it is classified into hospitals and specialty surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the medium viscosity segment held a high share of the market in 2023.
As per application, the kyphoplasty segment acquired a high stake in the market in 2023.
Depending on end user, the hospitals segment was the highest shareholder of the market in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The key players operating in the global bone cement for spine market include Cardinal Health, Meta Biomed Co., Ltd, Heraeus Medical GmbH, Shanghai Rebone, Tecres S.P.A, OSARTIS GmbH, Stryker Corporation, Johnson & Johnson, Heraeus Medical, Smith & Nephew plc, and Medtronic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.
Key Market Segments
By Type
Low Viscosity
Medium Viscosity
High Viscosity
By Application
Vertebroplasty
Kyphoplasty
By End User
Hospitals
Specialty Surgical Centers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Cardinal Health
Meta Biomed Co., Ltd
Heraeus Medical GmbH
Shanghai Rebone, Tecres S.P.A
OSARTIS GmbH
Stryker Corporation
Johnson & Johnson
Heraeus Medical
Smith & Nephew plc
Medtronic
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: BONE CEMENT FOR SPINE MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Low Viscosity
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Medium Viscosity
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. High Viscosity
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- CHAPTER 5: BONE CEMENT FOR SPINE MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Vertebroplasty
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Kyphoplasty
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- CHAPTER 6: BONE CEMENT FOR SPINE MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Specialty Surgical Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- CHAPTER 7: BONE CEMENT FOR SPINE MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Bone Cement for Spine Market
- 7.2.6.1. Market Size and Forecast, By Type
- 7.2.6.2. Market Size and Forecast, By Application
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Bone Cement for Spine Market
- 7.2.7.1. Market Size and Forecast, By Type
- 7.2.7.2. Market Size and Forecast, By Application
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Bone Cement for Spine Market
- 7.2.8.1. Market Size and Forecast, By Type
- 7.2.8.2. Market Size and Forecast, By Application
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Bone Cement for Spine Market
- 7.3.6.1. Market Size and Forecast, By Type
- 7.3.6.2. Market Size and Forecast, By Application
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Bone Cement for Spine Market
- 7.3.7.1. Market Size and Forecast, By Type
- 7.3.7.2. Market Size and Forecast, By Application
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. UK Bone Cement for Spine Market
- 7.3.8.1. Market Size and Forecast, By Type
- 7.3.8.2. Market Size and Forecast, By Application
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Bone Cement for Spine Market
- 7.3.9.1. Market Size and Forecast, By Type
- 7.3.9.2. Market Size and Forecast, By Application
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Bone Cement for Spine Market
- 7.3.10.1. Market Size and Forecast, By Type
- 7.3.10.2. Market Size and Forecast, By Application
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Bone Cement for Spine Market
- 7.3.11.1. Market Size and Forecast, By Type
- 7.3.11.2. Market Size and Forecast, By Application
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Bone Cement for Spine Market
- 7.4.6.1. Market Size and Forecast, By Type
- 7.4.6.2. Market Size and Forecast, By Application
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Bone Cement for Spine Market
- 7.4.7.1. Market Size and Forecast, By Type
- 7.4.7.2. Market Size and Forecast, By Application
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. Australia Bone Cement for Spine Market
- 7.4.8.1. Market Size and Forecast, By Type
- 7.4.8.2. Market Size and Forecast, By Application
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. India Bone Cement for Spine Market
- 7.4.9.1. Market Size and Forecast, By Type
- 7.4.9.2. Market Size and Forecast, By Application
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Bone Cement for Spine Market
- 7.4.10.1. Market Size and Forecast, By Type
- 7.4.10.2. Market Size and Forecast, By Application
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Bone Cement for Spine Market
- 7.4.11.1. Market Size and Forecast, By Type
- 7.4.11.2. Market Size and Forecast, By Application
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Bone Cement for Spine Market
- 7.5.6.1. Market Size and Forecast, By Type
- 7.5.6.2. Market Size and Forecast, By Application
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia Bone Cement for Spine Market
- 7.5.7.1. Market Size and Forecast, By Type
- 7.5.7.2. Market Size and Forecast, By Application
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. South Africa Bone Cement for Spine Market
- 7.5.8.1. Market Size and Forecast, By Type
- 7.5.8.2. Market Size and Forecast, By Application
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Bone Cement for Spine Market
- 7.5.9.1. Market Size and Forecast, By Type
- 7.5.9.2. Market Size and Forecast, By Application
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Cardinal Health
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Meta Biomed Co., Ltd
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Heraeus Medical GmbH
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Shanghai Rebone, Tecres S.P.A
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. OSARTIS GmbH
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Stryker Corporation
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Johnson And Johnson
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Heraeus Medical
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Smith And Nephew Plc
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Medtronic
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 2. BONE CEMENT FOR SPINE MARKET FOR LOW VISCOSITY, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 3. BONE CEMENT FOR SPINE MARKET FOR MEDIUM VISCOSITY, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 4. BONE CEMENT FOR SPINE MARKET FOR HIGH VISCOSITY, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 5. GLOBAL BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 6. BONE CEMENT FOR SPINE MARKET FOR VERTEBROPLASTY, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 7. BONE CEMENT FOR SPINE MARKET FOR KYPHOPLASTY, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 8. GLOBAL BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 9. BONE CEMENT FOR SPINE MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 10. BONE CEMENT FOR SPINE MARKET FOR SPECIALTY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 11. BONE CEMENT FOR SPINE MARKET, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 12. NORTH AMERICA BONE CEMENT FOR SPINE MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 13. NORTH AMERICA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 14. NORTH AMERICA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 15. NORTH AMERICA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 16. U.S. BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 17. U.S. BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 18. U.S. BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 19. CANADA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 20. CANADA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 21. CANADA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 22. MEXICO BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 23. MEXICO BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 24. MEXICO BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 25. EUROPE BONE CEMENT FOR SPINE MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 26. EUROPE BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 27. EUROPE BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 28. EUROPE BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 29. GERMANY BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 30. GERMANY BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 31. GERMANY BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 32. FRANCE BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 33. FRANCE BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 34. FRANCE BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 35. UK BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 36. UK BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 37. UK BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 38. ITALY BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 39. ITALY BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 40. ITALY BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 41. SPAIN BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 42. SPAIN BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 43. SPAIN BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 44. REST OF EUROPE BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 45. REST OF EUROPE BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 46. REST OF EUROPE BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 47. ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 48. ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 49. ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 50. ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 51. JAPAN BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 52. JAPAN BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 53. JAPAN BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 54. CHINA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 55. CHINA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 56. CHINA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 57. AUSTRALIA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 58. AUSTRALIA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 59. AUSTRALIA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 60. INDIA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 61. INDIA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 62. INDIA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 63. SOUTH KOREA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 64. SOUTH KOREA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 65. SOUTH KOREA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 66. REST OF ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 67. REST OF ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 68. REST OF ASIA-PACIFIC BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 69. LAMEA BONE CEMENT FOR SPINE MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 70. LAMEA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 71. LAMEA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 72. LAMEA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 73. BRAZIL BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 74. BRAZIL BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 75. BRAZIL BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 76. SAUDI ARABIA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 77. SAUDI ARABIA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 78. SAUDI ARABIA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 79. SOUTH AFRICA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 80. SOUTH AFRICA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 81. SOUTH AFRICA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 82. REST OF LAMEA BONE CEMENT FOR SPINE MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 83. REST OF LAMEA BONE CEMENT FOR SPINE MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 84. REST OF LAMEA BONE CEMENT FOR SPINE MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 85. CARDINAL HEALTH: KEY EXECUTIVES
- TABLE 86. CARDINAL HEALTH: COMPANY SNAPSHOT
- TABLE 87. CARDINAL HEALTH: OPERATING SEGMENTS
- TABLE 88. CARDINAL HEALTH: PRODUCT PORTFOLIO
- TABLE 89. CARDINAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 90. META BIOMED CO., LTD: KEY EXECUTIVES
- TABLE 91. META BIOMED CO., LTD: COMPANY SNAPSHOT
- TABLE 92. META BIOMED CO., LTD: OPERATING SEGMENTS
- TABLE 93. META BIOMED CO., LTD: PRODUCT PORTFOLIO
- TABLE 94. META BIOMED CO., LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 95. HERAEUS MEDICAL GMBH: KEY EXECUTIVES
- TABLE 96. HERAEUS MEDICAL GMBH: COMPANY SNAPSHOT
- TABLE 97. HERAEUS MEDICAL GMBH: OPERATING SEGMENTS
- TABLE 98. HERAEUS MEDICAL GMBH: PRODUCT PORTFOLIO
- TABLE 99. HERAEUS MEDICAL GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 100. SHANGHAI REBONE, TECRES S.P.A: KEY EXECUTIVES
- TABLE 101. SHANGHAI REBONE, TECRES S.P.A: COMPANY SNAPSHOT
- TABLE 102. SHANGHAI REBONE, TECRES S.P.A: OPERATING SEGMENTS
- TABLE 103. SHANGHAI REBONE, TECRES S.P.A: PRODUCT PORTFOLIO
- TABLE 104. SHANGHAI REBONE, TECRES S.P.A: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 105. OSARTIS GMBH: KEY EXECUTIVES
- TABLE 106. OSARTIS GMBH: COMPANY SNAPSHOT
- TABLE 107. OSARTIS GMBH: OPERATING SEGMENTS
- TABLE 108. OSARTIS GMBH: PRODUCT PORTFOLIO
- TABLE 109. OSARTIS GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 110. STRYKER CORPORATION: KEY EXECUTIVES
- TABLE 111. STRYKER CORPORATION: COMPANY SNAPSHOT
- TABLE 112. STRYKER CORPORATION: OPERATING SEGMENTS
- TABLE 113. STRYKER CORPORATION: PRODUCT PORTFOLIO
- TABLE 114. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 115. JOHNSON AND JOHNSON: KEY EXECUTIVES
- TABLE 116. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
- TABLE 117. JOHNSON AND JOHNSON: OPERATING SEGMENTS
- TABLE 118. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
- TABLE 119. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 120. HERAEUS MEDICAL: KEY EXECUTIVES
- TABLE 121. HERAEUS MEDICAL: COMPANY SNAPSHOT
- TABLE 122. HERAEUS MEDICAL: OPERATING SEGMENTS
- TABLE 123. HERAEUS MEDICAL: PRODUCT PORTFOLIO
- TABLE 124. HERAEUS MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 125. SMITH AND NEPHEW PLC: KEY EXECUTIVES
- TABLE 126. SMITH AND NEPHEW PLC: COMPANY SNAPSHOT
- TABLE 127. SMITH AND NEPHEW PLC: OPERATING SEGMENTS
- TABLE 128. SMITH AND NEPHEW PLC: PRODUCT PORTFOLIO
- TABLE 129. SMITH AND NEPHEW PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 130. MEDTRONIC: KEY EXECUTIVES
- TABLE 131. MEDTRONIC: COMPANY SNAPSHOT
- TABLE 132. MEDTRONIC: OPERATING SEGMENTS
- TABLE 133. MEDTRONIC: PRODUCT PORTFOLIO
- TABLE 134. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL BONE CEMENT FOR SPINE MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF BONE CEMENT FOR SPINE MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN BONE CEMENT FOR SPINE MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBONE CEMENT FOR SPINE MARKET
- FIGURE 10. GLOBAL BONE CEMENT FOR SPINE MARKET SEGMENTATION, BY TYPE
- FIGURE 11. BONE CEMENT FOR SPINE MARKET FOR LOW VISCOSITY, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 12. BONE CEMENT FOR SPINE MARKET FOR MEDIUM VISCOSITY, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 13. BONE CEMENT FOR SPINE MARKET FOR HIGH VISCOSITY, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 14. GLOBAL BONE CEMENT FOR SPINE MARKET SEGMENTATION, BY APPLICATION
- FIGURE 15. BONE CEMENT FOR SPINE MARKET FOR VERTEBROPLASTY, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 16. BONE CEMENT FOR SPINE MARKET FOR KYPHOPLASTY, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 17. GLOBAL BONE CEMENT FOR SPINE MARKET SEGMENTATION, BY END USER
- FIGURE 18. BONE CEMENT FOR SPINE MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 19. BONE CEMENT FOR SPINE MARKET FOR SPECIALTY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 24. COMPETITIVE DASHBOARD
- FIGURE 25. COMPETITIVE HEATMAP: BONE CEMENT FOR SPINE MARKET
- FIGURE 26. TOP PLAYER POSITIONING, 2023
- FIGURE 27. CARDINAL HEALTH: NET SALES, 2021-2023 ($MILLION)
- FIGURE 28. CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 29. CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 30. META BIOMED CO., LTD: NET SALES, 2021-2023 ($MILLION)
- FIGURE 31. META BIOMED CO., LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 32. META BIOMED CO., LTD: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 33. HERAEUS MEDICAL GMBH: NET SALES, 2021-2023 ($MILLION)
- FIGURE 34. HERAEUS MEDICAL GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. HERAEUS MEDICAL GMBH: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. SHANGHAI REBONE, TECRES S.P.A: NET SALES, 2021-2023 ($MILLION)
- FIGURE 37. SHANGHAI REBONE, TECRES S.P.A: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. SHANGHAI REBONE, TECRES S.P.A: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. OSARTIS GMBH: NET SALES, 2021-2023 ($MILLION)
- FIGURE 40. OSARTIS GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. OSARTIS GMBH: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. STRYKER CORPORATION: NET SALES, 2021-2023 ($MILLION)
- FIGURE 43. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($MILLION)
- FIGURE 46. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. HERAEUS MEDICAL: NET SALES, 2021-2023 ($MILLION)
- FIGURE 49. HERAEUS MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. HERAEUS MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 51. SMITH AND NEPHEW PLC: NET SALES, 2021-2023 ($MILLION)
- FIGURE 52. SMITH AND NEPHEW PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 53. SMITH AND NEPHEW PLC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 54. MEDTRONIC: NET SALES, 2021-2023 ($MILLION)
- FIGURE 55. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 56. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook